compounded semaglutide from hers Eli Lilly and Novo Nordisk are positioned for long-term growth because they're at the center of one of the biggest healthcare trends in the world. Their weight-loss drugs aren't just helping people Hims GLP-1 Weight Loss: What

Description

Important Information About Compounded Medications Compounded medications are not reviewed or approved by the FDA for safety or effectiveness

J.BonnerT

Tirzepatide (Mounjaro/Zepbound) offers dual GLP-1 and GIP agonism, achieving approximately 20.9% weight loss

In December 2025, CMS announced the Medicare GLP-1 Bridge demonstration, a short-term program that will allow eligible Medicare beneficiaries to access GLP-1 obesity medications at a $50/month co-pay starting July 2026 , using a centralized processor to manage PA, claims adjudication, and payment ( [18] )

For example, if a patient experiences increased gastrointestinal side effects from a GLP-1 agonist while on hormonal therapy, adjustments may be necessary to optimise comfort and therapeutic outcomes